Rapidly Growing Scalp Nodule

Article Type
Quiz
Changed
Thu, 01/10/2019 - 13:33
Display Headline
Rapidly Growing Scalp Nodule
Author(s)
Kabeer K. Shah, DO
Mara Dacso, MD
Brittany Schupbach, PA-C
Dirk M. Elston, MD

Cutaneous Metastasis of Pulmonary Adenocarcinoma

Cutaneous metastasis of pulmonary adenocarcinoma (CMPA) is a rare phenomenon with an overall survival rate of less than 5 months.1,2 Often, CMPA can be the heralding feature of an aggressive systemic malignancy in 2.8% to 22% of reported cases.2-4 Clinically, CMPAs often present as fixed, violaceous, ulcerated nodules on the chest wall, scalp, or site of a prior procedure.3,5,6 Other clinical presentations have been described including zosteriform and inflammatory carcinomalike CMPA and CMPA on the tip of the nose.7 Histologically, CMPA presents as a subdermal collection of atypical glands arranged as clustered aggregates of infiltrative glands penetrating the dermal stroma (quiz image). The atypical glands have large oval nuclei with high nuclear to cytoplasm ratios with scant pale cytoplasm.

Cutaneous metastasis of pulmonary adenocarcinoma is difficult to distinguish from other metastatic or primary glandular malignancies based on histology alone. Immunohistochemical analysis can aid in the diagnosis of the primary tumor. Pulmonary adenocarcinomas are positive for cytokeratin (CK) 7 and thyroid transcription factor 1 (TTF-1), and they are negative for CK5/6 and CK20.7 The differential diagnosis for CMPA includes other internal malignancies such as invasive ductal adenocarcinoma of the breast and gastrointestinal adenocarcinomas (eg, gastric or colorectal carcinoma [CRC]). Additionally, endometriosis and primary sebaceous carcinomas can mimic cutaneous metastatic adenocarcinomas.

Endometriosis can mimic adenocarcinoma, especially when presenting as a subdermal nodule. However, the scattered dermal glands are cytologically banal and are surrounded by uterine-type stroma and extravasated hemorrhage, a classic presentation of endometriosis (Figure 1).

Figure 1. Excisional biopsy shows foci of cellular aggregates deep within the dermis (inset [H&E, original magnification ×1]). At higher magnification, pseudostratified glandular structures are cuffed by uterine-type stroma and extravasated red blood cells characteristic of endometriosis (H&E, original magnification ×400).

Invasive ductal carcinoma of the breast is one of the most common cutaneous metastases of internal malignancy.3 Clinically, these lesions present on the chest wall or abdomen as flesh-colored nodules. Histopathology generally reveals either tubular or single tumor cells infiltrating the dermis with surrounding desmoplastic fibrosis (Figure 2). Immunohistochemistry typically is positive for CK7, estrogen receptor, and mammaglobin, and negative for CK20, CK5/6, and TTF-1.

Figure 2. A collection of infiltrative glands with intervening stroma present within the epidermis in invasive ductal carcinoma of the breast. The tumor was moderately differentiated with a paucity of tubular structures. The atypical islands of tumor had a characteristic gray eosinophilic cytoplasm and large pleomorphic nuclei (H&E, original magnification ×400 [inset, original magnification ×10]).

Gastrointestinal adenocarcinomas encompass a variety of primary sites that can metastasize to the skin including CRC. Clinically, cutaneous metastases of CRC present as multiple nodules on the trunk, abdomen, or umbilicus (also known as Sister Mary Joseph nodule).7,8 Distinguishing CRC as the primary site of origin can be difficult; however, there are subtle differences depending on the histologic subtype. In well-differentiated CRCs, well-defined atypical glands are haphazardly arranged within the dermis (Figure 3), while poorly differentiated lesions can present as single cells or with a signet ring-like morphology (Figure 4). For perianal lesions, extramammary Paget disease should be considered when biopsies show large, amphophilic, intraepithelial cells. These lesions often present with mucin and CK20 expression and are frequently associated with colorectal malignancies.9 Another characteristic feature of CRC is central necrosis with karyorrhectic debris, known as dirty necrosis. Immunohistochemical analysis typically shows expression of caudal type homeobox 2 and CK20 with infrequent expression of CK7 and no expression of TTF-1; however, additional clinical history (eg, history of colorectal adenocarcinoma, positive fecal occult blood test) often is the best distinguishing feature. 

Figure 3. A dermal collection of haphazardly arranged glands with central luminal necrosis and surrounding desmoplastic fibrosis in a colorectal carcinoma (H&E, original magnification ×200 [inset, original magnification ×10]).

Figure 4. Percolating within the epidermis is a pagetoid collection of signet ring–like cells that are periodic acid–Schiff (inset [original magnification ×100]), cytokeratin 20, and caudal type homeobox 2 positive, confirming presence of a colorectal carcinoma and signet ring–like goblet cells producing mucin (H&E, original magnification ×100).

 

 

Primary sebaceous carcinoma also can mimic metastatic adenocarcinoma within the skin and is histologically similar to metastatic adenocarcinomas. The most distinguishing feature is sebaceous differentiation characterized by sebocytes, which have a vacuolated cytoplasm giving the nucleus a scalloped appearance, frequently with adjacent ductlike structures (Figure 5). Epidermotropism sometimes is present in sebaceous carcinomas but cannot be relied on as a distinguishing feature. Immunohistochemical analysis also is a helpful tool; these tumors typically are positive for p63 and podoplanin, distinguishing them from negative-staining metastatic adenocarcinomas.10,11 

Figure 5. Within the dermis is a dense collection of atypical cells (inset [H&E, original magnification ×20]) with an unaffected overlying epidermis. At higher magnification, the atypical cells are elongated with abundant eosinophilic cytoplasm. Ductlike structures and vacuolated cytoplasm are characteristic of sebaceous carcinoma (H&E, original magnification ×400).

References
  1. Terashima T, Kanazawa M. Lung cancer with skin metastasis. Chest. 1994;106:1448-1450.
  2. Song Z, Lin B, Shao L, et al. Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis. J Cancer Res Clin Oncol. 2012;138:1613-1617.
  3. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29(2, pt 1):228-236.
  4. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004;31:419-430.
  5. Chang SE, Choi JC, Moon KC. A papillary carcinoma: cutaneous metastases from lung cancer. J Dermatol. 2001;28:110-111.
  6. Snow S, Madjar D, Reizner G, et al. Renal cell carcinoma metastatic to the scalp: case report and review of the literature. Dermatol Surg. 2001;27:192-194.
  7. Alcaraz I, Cerroni L, Rutten A, et al. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol. 2012;34:347-393.
  8. Schwartz IS. Sister (Mary?) Joseph's nodule. N Engl J Med. 1987;316:1348-1349.
  9. Goldblum J, Hart W. Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol. 1998;22:170-179.
  10. Ivan D, Nash J, Preito V, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2006;34:474-480.
  11. Liang H, Wu H, Giorgadze T, et al. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol. 2007;31:304-310.
Article PDF
CT098009156.PDF
Author and Disclosure Information

Dr. Shah is from the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Dr. Dacso and Ms. Schupbach are from the Center for Dermatology and Cosmetic Laser Surgery, Plano, Texas. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston. 

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, 11th Floor, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Issue
Cutis - 98(3)
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Page Number
156, 167-168
Sections
Dermpath Diagnosis
Author(s)
Kabeer K. Shah, DO
Mara Dacso, MD
Brittany Schupbach, PA-C
Dirk M. Elston, MD
Author(s)
Kabeer K. Shah, DO
Mara Dacso, MD
Brittany Schupbach, PA-C
Dirk M. Elston, MD
Author and Disclosure Information

Dr. Shah is from the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Dr. Dacso and Ms. Schupbach are from the Center for Dermatology and Cosmetic Laser Surgery, Plano, Texas. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston. 

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, 11th Floor, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Author and Disclosure Information

Dr. Shah is from the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Dr. Dacso and Ms. Schupbach are from the Center for Dermatology and Cosmetic Laser Surgery, Plano, Texas. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston. 

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, 11th Floor, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Article PDF
CT098009156.PDF
Article PDF
CT098009156.PDF

Cutaneous Metastasis of Pulmonary Adenocarcinoma

Cutaneous metastasis of pulmonary adenocarcinoma (CMPA) is a rare phenomenon with an overall survival rate of less than 5 months.1,2 Often, CMPA can be the heralding feature of an aggressive systemic malignancy in 2.8% to 22% of reported cases.2-4 Clinically, CMPAs often present as fixed, violaceous, ulcerated nodules on the chest wall, scalp, or site of a prior procedure.3,5,6 Other clinical presentations have been described including zosteriform and inflammatory carcinomalike CMPA and CMPA on the tip of the nose.7 Histologically, CMPA presents as a subdermal collection of atypical glands arranged as clustered aggregates of infiltrative glands penetrating the dermal stroma (quiz image). The atypical glands have large oval nuclei with high nuclear to cytoplasm ratios with scant pale cytoplasm.

Cutaneous metastasis of pulmonary adenocarcinoma is difficult to distinguish from other metastatic or primary glandular malignancies based on histology alone. Immunohistochemical analysis can aid in the diagnosis of the primary tumor. Pulmonary adenocarcinomas are positive for cytokeratin (CK) 7 and thyroid transcription factor 1 (TTF-1), and they are negative for CK5/6 and CK20.7 The differential diagnosis for CMPA includes other internal malignancies such as invasive ductal adenocarcinoma of the breast and gastrointestinal adenocarcinomas (eg, gastric or colorectal carcinoma [CRC]). Additionally, endometriosis and primary sebaceous carcinomas can mimic cutaneous metastatic adenocarcinomas.

Endometriosis can mimic adenocarcinoma, especially when presenting as a subdermal nodule. However, the scattered dermal glands are cytologically banal and are surrounded by uterine-type stroma and extravasated hemorrhage, a classic presentation of endometriosis (Figure 1).

Figure 1. Excisional biopsy shows foci of cellular aggregates deep within the dermis (inset [H&E, original magnification ×1]). At higher magnification, pseudostratified glandular structures are cuffed by uterine-type stroma and extravasated red blood cells characteristic of endometriosis (H&E, original magnification ×400).

Invasive ductal carcinoma of the breast is one of the most common cutaneous metastases of internal malignancy.3 Clinically, these lesions present on the chest wall or abdomen as flesh-colored nodules. Histopathology generally reveals either tubular or single tumor cells infiltrating the dermis with surrounding desmoplastic fibrosis (Figure 2). Immunohistochemistry typically is positive for CK7, estrogen receptor, and mammaglobin, and negative for CK20, CK5/6, and TTF-1.

Figure 2. A collection of infiltrative glands with intervening stroma present within the epidermis in invasive ductal carcinoma of the breast. The tumor was moderately differentiated with a paucity of tubular structures. The atypical islands of tumor had a characteristic gray eosinophilic cytoplasm and large pleomorphic nuclei (H&E, original magnification ×400 [inset, original magnification ×10]).

Gastrointestinal adenocarcinomas encompass a variety of primary sites that can metastasize to the skin including CRC. Clinically, cutaneous metastases of CRC present as multiple nodules on the trunk, abdomen, or umbilicus (also known as Sister Mary Joseph nodule).7,8 Distinguishing CRC as the primary site of origin can be difficult; however, there are subtle differences depending on the histologic subtype. In well-differentiated CRCs, well-defined atypical glands are haphazardly arranged within the dermis (Figure 3), while poorly differentiated lesions can present as single cells or with a signet ring-like morphology (Figure 4). For perianal lesions, extramammary Paget disease should be considered when biopsies show large, amphophilic, intraepithelial cells. These lesions often present with mucin and CK20 expression and are frequently associated with colorectal malignancies.9 Another characteristic feature of CRC is central necrosis with karyorrhectic debris, known as dirty necrosis. Immunohistochemical analysis typically shows expression of caudal type homeobox 2 and CK20 with infrequent expression of CK7 and no expression of TTF-1; however, additional clinical history (eg, history of colorectal adenocarcinoma, positive fecal occult blood test) often is the best distinguishing feature. 

Figure 3. A dermal collection of haphazardly arranged glands with central luminal necrosis and surrounding desmoplastic fibrosis in a colorectal carcinoma (H&E, original magnification ×200 [inset, original magnification ×10]).

Figure 4. Percolating within the epidermis is a pagetoid collection of signet ring–like cells that are periodic acid–Schiff (inset [original magnification ×100]), cytokeratin 20, and caudal type homeobox 2 positive, confirming presence of a colorectal carcinoma and signet ring–like goblet cells producing mucin (H&E, original magnification ×100).

 

 

Primary sebaceous carcinoma also can mimic metastatic adenocarcinoma within the skin and is histologically similar to metastatic adenocarcinomas. The most distinguishing feature is sebaceous differentiation characterized by sebocytes, which have a vacuolated cytoplasm giving the nucleus a scalloped appearance, frequently with adjacent ductlike structures (Figure 5). Epidermotropism sometimes is present in sebaceous carcinomas but cannot be relied on as a distinguishing feature. Immunohistochemical analysis also is a helpful tool; these tumors typically are positive for p63 and podoplanin, distinguishing them from negative-staining metastatic adenocarcinomas.10,11 

Figure 5. Within the dermis is a dense collection of atypical cells (inset [H&E, original magnification ×20]) with an unaffected overlying epidermis. At higher magnification, the atypical cells are elongated with abundant eosinophilic cytoplasm. Ductlike structures and vacuolated cytoplasm are characteristic of sebaceous carcinoma (H&E, original magnification ×400).

Cutaneous Metastasis of Pulmonary Adenocarcinoma

Cutaneous metastasis of pulmonary adenocarcinoma (CMPA) is a rare phenomenon with an overall survival rate of less than 5 months.1,2 Often, CMPA can be the heralding feature of an aggressive systemic malignancy in 2.8% to 22% of reported cases.2-4 Clinically, CMPAs often present as fixed, violaceous, ulcerated nodules on the chest wall, scalp, or site of a prior procedure.3,5,6 Other clinical presentations have been described including zosteriform and inflammatory carcinomalike CMPA and CMPA on the tip of the nose.7 Histologically, CMPA presents as a subdermal collection of atypical glands arranged as clustered aggregates of infiltrative glands penetrating the dermal stroma (quiz image). The atypical glands have large oval nuclei with high nuclear to cytoplasm ratios with scant pale cytoplasm.

Cutaneous metastasis of pulmonary adenocarcinoma is difficult to distinguish from other metastatic or primary glandular malignancies based on histology alone. Immunohistochemical analysis can aid in the diagnosis of the primary tumor. Pulmonary adenocarcinomas are positive for cytokeratin (CK) 7 and thyroid transcription factor 1 (TTF-1), and they are negative for CK5/6 and CK20.7 The differential diagnosis for CMPA includes other internal malignancies such as invasive ductal adenocarcinoma of the breast and gastrointestinal adenocarcinomas (eg, gastric or colorectal carcinoma [CRC]). Additionally, endometriosis and primary sebaceous carcinomas can mimic cutaneous metastatic adenocarcinomas.

Endometriosis can mimic adenocarcinoma, especially when presenting as a subdermal nodule. However, the scattered dermal glands are cytologically banal and are surrounded by uterine-type stroma and extravasated hemorrhage, a classic presentation of endometriosis (Figure 1).

Figure 1. Excisional biopsy shows foci of cellular aggregates deep within the dermis (inset [H&E, original magnification ×1]). At higher magnification, pseudostratified glandular structures are cuffed by uterine-type stroma and extravasated red blood cells characteristic of endometriosis (H&E, original magnification ×400).

Invasive ductal carcinoma of the breast is one of the most common cutaneous metastases of internal malignancy.3 Clinically, these lesions present on the chest wall or abdomen as flesh-colored nodules. Histopathology generally reveals either tubular or single tumor cells infiltrating the dermis with surrounding desmoplastic fibrosis (Figure 2). Immunohistochemistry typically is positive for CK7, estrogen receptor, and mammaglobin, and negative for CK20, CK5/6, and TTF-1.

Figure 2. A collection of infiltrative glands with intervening stroma present within the epidermis in invasive ductal carcinoma of the breast. The tumor was moderately differentiated with a paucity of tubular structures. The atypical islands of tumor had a characteristic gray eosinophilic cytoplasm and large pleomorphic nuclei (H&E, original magnification ×400 [inset, original magnification ×10]).

Gastrointestinal adenocarcinomas encompass a variety of primary sites that can metastasize to the skin including CRC. Clinically, cutaneous metastases of CRC present as multiple nodules on the trunk, abdomen, or umbilicus (also known as Sister Mary Joseph nodule).7,8 Distinguishing CRC as the primary site of origin can be difficult; however, there are subtle differences depending on the histologic subtype. In well-differentiated CRCs, well-defined atypical glands are haphazardly arranged within the dermis (Figure 3), while poorly differentiated lesions can present as single cells or with a signet ring-like morphology (Figure 4). For perianal lesions, extramammary Paget disease should be considered when biopsies show large, amphophilic, intraepithelial cells. These lesions often present with mucin and CK20 expression and are frequently associated with colorectal malignancies.9 Another characteristic feature of CRC is central necrosis with karyorrhectic debris, known as dirty necrosis. Immunohistochemical analysis typically shows expression of caudal type homeobox 2 and CK20 with infrequent expression of CK7 and no expression of TTF-1; however, additional clinical history (eg, history of colorectal adenocarcinoma, positive fecal occult blood test) often is the best distinguishing feature. 

Figure 3. A dermal collection of haphazardly arranged glands with central luminal necrosis and surrounding desmoplastic fibrosis in a colorectal carcinoma (H&E, original magnification ×200 [inset, original magnification ×10]).

Figure 4. Percolating within the epidermis is a pagetoid collection of signet ring–like cells that are periodic acid–Schiff (inset [original magnification ×100]), cytokeratin 20, and caudal type homeobox 2 positive, confirming presence of a colorectal carcinoma and signet ring–like goblet cells producing mucin (H&E, original magnification ×100).

 

 

Primary sebaceous carcinoma also can mimic metastatic adenocarcinoma within the skin and is histologically similar to metastatic adenocarcinomas. The most distinguishing feature is sebaceous differentiation characterized by sebocytes, which have a vacuolated cytoplasm giving the nucleus a scalloped appearance, frequently with adjacent ductlike structures (Figure 5). Epidermotropism sometimes is present in sebaceous carcinomas but cannot be relied on as a distinguishing feature. Immunohistochemical analysis also is a helpful tool; these tumors typically are positive for p63 and podoplanin, distinguishing them from negative-staining metastatic adenocarcinomas.10,11 

Figure 5. Within the dermis is a dense collection of atypical cells (inset [H&E, original magnification ×20]) with an unaffected overlying epidermis. At higher magnification, the atypical cells are elongated with abundant eosinophilic cytoplasm. Ductlike structures and vacuolated cytoplasm are characteristic of sebaceous carcinoma (H&E, original magnification ×400).

References
  1. Terashima T, Kanazawa M. Lung cancer with skin metastasis. Chest. 1994;106:1448-1450.
  2. Song Z, Lin B, Shao L, et al. Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis. J Cancer Res Clin Oncol. 2012;138:1613-1617.
  3. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29(2, pt 1):228-236.
  4. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004;31:419-430.
  5. Chang SE, Choi JC, Moon KC. A papillary carcinoma: cutaneous metastases from lung cancer. J Dermatol. 2001;28:110-111.
  6. Snow S, Madjar D, Reizner G, et al. Renal cell carcinoma metastatic to the scalp: case report and review of the literature. Dermatol Surg. 2001;27:192-194.
  7. Alcaraz I, Cerroni L, Rutten A, et al. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol. 2012;34:347-393.
  8. Schwartz IS. Sister (Mary?) Joseph's nodule. N Engl J Med. 1987;316:1348-1349.
  9. Goldblum J, Hart W. Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol. 1998;22:170-179.
  10. Ivan D, Nash J, Preito V, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2006;34:474-480.
  11. Liang H, Wu H, Giorgadze T, et al. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol. 2007;31:304-310.
References
  1. Terashima T, Kanazawa M. Lung cancer with skin metastasis. Chest. 1994;106:1448-1450.
  2. Song Z, Lin B, Shao L, et al. Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis. J Cancer Res Clin Oncol. 2012;138:1613-1617.
  3. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29(2, pt 1):228-236.
  4. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004;31:419-430.
  5. Chang SE, Choi JC, Moon KC. A papillary carcinoma: cutaneous metastases from lung cancer. J Dermatol. 2001;28:110-111.
  6. Snow S, Madjar D, Reizner G, et al. Renal cell carcinoma metastatic to the scalp: case report and review of the literature. Dermatol Surg. 2001;27:192-194.
  7. Alcaraz I, Cerroni L, Rutten A, et al. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol. 2012;34:347-393.
  8. Schwartz IS. Sister (Mary?) Joseph's nodule. N Engl J Med. 1987;316:1348-1349.
  9. Goldblum J, Hart W. Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol. 1998;22:170-179.
  10. Ivan D, Nash J, Preito V, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2006;34:474-480.
  11. Liang H, Wu H, Giorgadze T, et al. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Am J Surg Pathol. 2007;31:304-310.
Issue
Cutis - 98(3)
Issue
Cutis - 98(3)
Page Number
156, 167-168
Page Number
156, 167-168
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Article Type
Quiz
Display Headline
Rapidly Growing Scalp Nodule
Display Headline
Rapidly Growing Scalp Nodule
Sections
Dermpath Diagnosis
Questionnaire Body

H&E, original magnification ×200 (original magnification ×400 [inset]).

A 67-year-old woman with no history of malignancy presented with a scalp nodule. The photomicrograph showed atypical glands forming a subepidermal nodule with pleomorphic cells characterized by scant eosinophilic cytoplasm and large prominent nucleoli. Immunohistochemical analysis revealed diffuse thyroid transcription factor 1 and cytokeratin 7 positivity.
 

Disallow All Ads
Teaser Media
Article PDF Media
Subscribe to Brittany Schupbach, PA-C